Seennabis blog author
Lily Tanaka
CBD & Therapeutic Strains Editor
Lily Tanaka has spent eight years cataloguing CBD-dominant and 1:1 cultivars across the global market. Her writing for Seennabis focuses on therapeutic-use genetics, low-THC strain selection for medical contexts, and the still-emerging science around minor cannabinoids (CBG, CBN, CBC).
CBD-dominant cannabisTherapeutic strainsLow-THC cultivarsMinor cannabinoids (CBG/CBN/CBC)Entourage effect research
Based in Osaka, Japan
Lily Tanaka hasn't published yet
Lily writes for the Seennabis editorial team and will be publishing on CBD-dominant cannabis and Therapeutic strains. Check back soon, or browse the rest of the team's coverage below.